These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A homogeneous assay for analysis of FMR1 promoter methylation in patients with fragile X syndrome. Dahl C; Grønskov K; Larsen LA; Guldberg P; Brøndum-Nielsen K Clin Chem; 2007 Apr; 53(4):790-3. PubMed ID: 17259243 [TBL] [Abstract][Full Text] [Related]
25. Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome. Coffee B; Zhang F; Ceman S; Warren ST; Reines D Am J Hum Genet; 2002 Oct; 71(4):923-32. PubMed ID: 12232854 [TBL] [Abstract][Full Text] [Related]
26. Defining the role of the CGGBP1 protein in FMR1 gene expression. Goracci M; Lanni S; Mancano G; Palumbo F; Chiurazzi P; Neri G; Tabolacci E Eur J Hum Genet; 2016 May; 24(5):697-703. PubMed ID: 26306647 [TBL] [Abstract][Full Text] [Related]
27. A methylation PCR method determines Hadd AG; Filipovic-Sadic S; Zhou L; Williams A; Latham GJ; Berry-Kravis E; Hall DA Clin Epigenetics; 2016; 8():130. PubMed ID: 27980694 [TBL] [Abstract][Full Text] [Related]
28. Single-locus enrichment without amplification for sequencing and direct detection of epigenetic modifications. Pham TT; Yin J; Eid JS; Adams E; Lam R; Turner SW; Loomis EW; Wang JY; Hagerman PJ; Hanes JW Mol Genet Genomics; 2016 Jun; 291(3):1491-504. PubMed ID: 26825750 [TBL] [Abstract][Full Text] [Related]
29. Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene. Liu XS; Wu H; Krzisch M; Wu X; Graef J; Muffat J; Hnisz D; Li CH; Yuan B; Xu C; Li Y; Vershkov D; Cacace A; Young RA; Jaenisch R Cell; 2018 Feb; 172(5):979-992.e6. PubMed ID: 29456084 [TBL] [Abstract][Full Text] [Related]
30. Clinical Validation of Fragile X Syndrome Screening by DNA Methylation Array. Schenkel LC; Schwartz C; Skinner C; Rodenhiser DI; Ainsworth PJ; Pare G; Sadikovic B J Mol Diagn; 2016 Nov; 18(6):834-841. PubMed ID: 27585064 [TBL] [Abstract][Full Text] [Related]
31. Single-tube methylation-specific duplex-PCR assay for rapid and accurate diagnosis of Fragile X Mental Retardation 1-related disorders. Rajan-Babu IS; Teo CR; Lian M; Lee CG; Law HY; Chong SS Expert Rev Mol Diagn; 2015 Mar; 15(3):431-41. PubMed ID: 25583300 [TBL] [Abstract][Full Text] [Related]
32. Two novel intragenic variants in the FMR1 gene in patients with suspect clinical diagnosis of Fragile X syndrome and no CGG repeat expansion. Carroll R; Shaw M; Arvio M; Gardner A; Kumar R; Hodgson B; Heron S; McKenzie F; Järvelä I; Gecz J Eur J Med Genet; 2020 Oct; 63(10):104010. PubMed ID: 32688058 [TBL] [Abstract][Full Text] [Related]
33. Epigenetic mechanism of FMR1 inactivation in Fragile X syndrome. Hecht M; Tabib A; Kahan T; Orlanski S; Gropp M; Tabach Y; Yanuka O; Benvenisty N; Keshet I; Cedar H Int J Dev Biol; 2017; 61(3-4-5):285-292. PubMed ID: 28621425 [TBL] [Abstract][Full Text] [Related]
34. The distribution of repressive histone modifications on silenced FMR1 alleles provides clues to the mechanism of gene silencing in fragile X syndrome. Kumari D; Usdin K Hum Mol Genet; 2010 Dec; 19(23):4634-42. PubMed ID: 20843831 [TBL] [Abstract][Full Text] [Related]
35. Nucleosome assembly on methylated CGG triplet repeats in the fragile X mental retardation gene 1 promoter. Godde JS; Kass SU; Hirst MC; Wolffe AP J Biol Chem; 1996 Oct; 271(40):24325-8. PubMed ID: 8798682 [TBL] [Abstract][Full Text] [Related]
36. Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Jacquemont S; Curie A; des Portes V; Torrioli MG; Berry-Kravis E; Hagerman RJ; Ramos FJ; Cornish K; He Y; Paulding C; Neri G; Chen F; Hadjikhani N; Martinet D; Meyer J; Beckmann JS; Delange K; Brun A; Bussy G; Gasparini F; Hilse T; Floesser A; Branson J; Bilbe G; Johns D; Gomez-Mancilla B Sci Transl Med; 2011 Jan; 3(64):64ra1. PubMed ID: 21209411 [TBL] [Abstract][Full Text] [Related]
37. Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments. Tabolacci E; Pietrobono R; Moscato U; Oostra BA; Chiurazzi P; Neri G Eur J Hum Genet; 2005 May; 13(5):641-8. PubMed ID: 15741991 [TBL] [Abstract][Full Text] [Related]
38. Genome-wide analysis validates aberrant methylation in fragile X syndrome is specific to the FMR1 locus. Alisch RS; Wang T; Chopra P; Visootsak J; Conneely KN; Warren ST BMC Med Genet; 2013 Jan; 14():18. PubMed ID: 23356558 [TBL] [Abstract][Full Text] [Related]
39. [Method for the Molecular Cytogenetic Visualization of Fragile Site FRAXA]. Bobokova TS; Lemskaya NA; Kolesnikova IS; Yudkin DV Mol Biol (Mosk); 2017; 51(4):704-709. PubMed ID: 28900090 [TBL] [Abstract][Full Text] [Related]
40. Role of CTCF protein in regulating FMR1 locus transcription. Lanni S; Goracci M; Borrelli L; Mancano G; Chiurazzi P; Moscato U; Ferrè F; Helmer-Citterich M; Tabolacci E; Neri G PLoS Genet; 2013; 9(7):e1003601. PubMed ID: 23874213 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]